|
Before joining Cardium Therapeutics in November 2005, Dr. Novak served as Executive Director, Program Management and R&D at Metabasis Therapeutics, a publicly-traded biotechnology company. Prior to Metabasis she was Collateral Therapeutics' Vice President of Program Management from 2000 to 2003 and Senior Director of Program Management from 1997 to 2000 where she managed development programs related to Generx and other cardiovascular product candidates. From 1991 to 1997, Dr. Novak held various clinical research and development positions at Gensia, Inc., the most recent of which was Director of Research and Development Planning and Project Management. Prior to joining Gensia, Dr. Novak was a Clinical Project Manager at Alpha Therapeutic Corporation from 1987 to 1991. She also spent 12 years teaching and conducting research at leading academic institutions such as the University of Southern California School of Medicine. Dr. Novak received a Ph.D. in biological sciences from the University of California, Irvine. | 